You are here: Industry Insights > IND approval

News List

Ascletis Receives IND Approval for its HIV Drug ASC09F prnasia
April 13, 2020
Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F (ASC09/Ritonavir Fixed-Dose Combination).
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure firstwordpharma
December 17, 2019
TransThera Biosciences Co. Ltd, a clinical-stage biotechnology company based in Nanjing, China, announced today that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) application for TT-00920, a novel sma
I-Mab novel antibody gets IND approval in China biospectrumasia
October 08, 2019
TJD5 is currently being investigated in a Phase 1 clinical trial in the U.S. to assess the tolerability and preliminary efficacy both as a single agent and in combination with TECENTRIQ® (atezolizumab), a PD-L1 antibody marketed by Roche in the U.S., and
CStone receives IND approval in China for avapritinib study biospectrumasia
April 16, 2019
This is a stand-alone bridging trial consisting of a Phase I dose-escalation study and Phase II dose-expansion study, with the aim of determining the safety……
CStone receives IND approval in China for HDAC6 inhibitor CS3003 biospectrumasia
March 13, 2019
CS3003 is a small molecule inhibitor that selectively targets histone deacetylase 6 (HDAC6)
CStone received IND approval in China for HDAC6 inhibitor CS3003 en-cphi.cn
March 13, 2019
Cstone announced that the National Medical Products Administration (NMPA) recently approved company's histone deacetylase 6 (HDAC6) selective inhibitor CS3003 for Phase I clinical trial in China.
I-Mab gets USFDA IND approval for its proprietary TJC4 biospectrumasia
January 30, 2019
I-Mab Biopharma (I-Mab) announced recently that its IND application for TJC4, has been approved by the US Food & Drug Administration (FDA).